Screening for Atrial Fibrillation and Hypertension: Time to Act Now

Published: 17 October 2024

  • Views:

    Views Icon 13344
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This video series offers a comprehensive exploration of the latest advancements in the management of hypertension and atrial fibrillation (AF) as presented at ESC 2024 in London. Experts reflect on key updates to the guidelines, examining their impact on clinical practice, with a particular emphasis on gender-specific considerations. The series also delves into the critical relationship between hypertension and AF, highlighting the importance of home-based screening and introducing viewers to the latest innovations in AF detection technology.

 

For more information visit the Omron Academy following the link here.

This programme is supported by

Learning Objectives

  • To be familiar with the relation between hypertension and AF
  • To understand the importance of screening for AF and hypertension at home
  • To know the latest insights on AF detection innovations
  • To understand the risk of stroke in undiagnosed AF

Target Audience

  • Electrophysiologists
  • Interventional Cardiologists
  • Heart Failure Specialists
  • General Practitioners With a Special Interest in Cardiology

More from this programme

Part 1

Heart 2 Heart

Prof Alta Schutte and Prof Renate Schnabel provide an in-depth analysis of the recently presented guidelines for hypertension and AF unveiled at the ESC 2024.

Part 2

Gender Matters

Prof Alta Schutte and Prof Renate Schnabel discuss the hypertension and AF guidelines released at ESC 2024, with a focus on gender-specific considerations.

Part 3

ESC Symposium – Screening for AF and Hypertension: Time to Act Now

In this symposium from ESC 2024 in London, faculty explore the connection between hypertension and AF. They discuss the importance of home-based screening for both conditions and discover the latest innovations in AF detection.

Faculty Biographies

Ben Freedman

Ben Freedman

Director of External Affairs

Prof Ben Freedman is currently Director External Affairs at the Heart Research institute and Group Leader of its Heart Rhythm and Stroke Prevention Group. 

He is a Honorary Professor of Cardiology at the University of Sydney and former head of Department of Cardiology, Concord Hospital. 

In 2015 with five others he formed the AF SCREEN International Collaboration, which now has well over 2,000 members from 40 countries, including many of the foremost names in atrial fibrillation (AF) research. He has chaired the group in four important white papers/Frontiers Reviews on screening for AF to prevent stroke published in Circulation, the premier journal of the American Heart Association.

View full profile